Empify Inc. – Trademark Portfolio
Entity Type: 03
Empify Inc. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 1 filings in this category. The portfolio also extends into Class 9 (Computers & Electronics) across 4 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include WEALTHBUILDERS COMMUNITY. The owner is based in Bala Cynwyd, PA.
150 Monument Road, Suite 207
Bala Cynwyd, PA 19004
Showing of trademarks Trademarks
Trademark Classifications
Empify Inc.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Education; providing of training; entertainment; sporting and cultural activities
Insurance; financial affairs; monetary affairs; real estate affairs
Frequently Asked Questions
How many trademarks does Empify Inc. have?
Empify Inc. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.
What trademark classes does Empify Inc. file in?
Empify Inc. files trademarks across 4 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 9 (Computers & Electronics), Class 41 (Education & Entertainment), Class 36 (Insurance & Financial). Class 42 covers scientific and technological services; industrial analysis and research services.
What are Empify Inc.'s most well-known trademarks?
Empify Inc.'s registered trademark portfolio includes well-known marks such as WEALTHBUILDERS COMMUNITY. These are among 1 currently registered trademark in the portfolio.
What is Empify Inc.'s trademark registration success rate?
Empify Inc. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.